VYNE Therapeutics (VYNE) Misses Q1 EPS by 20c

VYNE Therapeutics (NASDAQ: VYNE) reported Q1 EPS of ($0.20). Revenue for the quarter came in at $200 thousand.

For earnings history and earnings-related data on VYNE Therapeutics (VYNE) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Lument Finance Trust (LFT) Misses Q2 EPS by 17c
• CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance